Concepedia

Gary D. Tollefson

GD

Statistics

Publications

111

Citations

15.1K

H-Index

57

Active since

1980

Affiliations

Eli Lilly (United States)(Current)

St. John Medical Center

Indiana University – Purdue University Indianapolis

Harvard University

Indiana University School of Medicine

Gary D. Tollefson is an author at Eli Lilly (United States) specializing in psychopharmacology, pharmacotherapy, and psychiatry.

Publications per year

1980–2009

111

Publications

111

Efficacy of Olanzapine and Olanzapine-Fluoxetine Combination in the Treatment of Bipolar I Depression

Mauricio Tohen, Eduard Vieta, Joseph R. Calabrese et al. · Archives of General Psychiatry · 2003 · 910 citations

, , +17

Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial

Gary D. Tollefson, Charles M. Beasley, P.V. Tran et al. · American Journal of Psychiatry · 1997 · 901 citations

, , +17

Olanzapine versus Placebo and Haloperidol

Charles M. Beasley, Gary D. Tollefson, P. Tran et al. · Neuropsychopharmacology · 1996 · 787 citations

, , +12

Double-Blind Comparison of Olanzapine Versus Risperidone in the Treatment of Schizophrenia and Other Psychotic Disorders

Pierre V. Trân, S.H. Hamilton, Amy J. Kuntz et al. · Journal of Clinical Psychopharmacology · 1997 · 718 citations

, , +15

Effects of Xanomeline, a Selective Muscarinic Receptor Agonist, on Cognitive Function and Behavioral Symptoms in Alzheimer Disease

N. Bodick, Walter Offen, Allan I. Levey et al. · Archives of Neurology · 1997 · 685 citations

, , +17

1–5 of 111